Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials

Overview of attention for article published in OncoTargets and therapy, June 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,375 followers.

Bortezomib-based post auttransplant therapy has tolerable side effects and improves responses and PFS in myeloma http://t.co/AcdCF42mHq

Reply Repost Favourite

Bortezomib-based post auttransplant therapy has tolerable side effects and improves responses and PFS in myeloma http://t.co/AcdCF42mHq

Reply Repost Favourite